1. DEAD-ly Affairs: The Roles of DEAD-Box Proteins on HIV-1 Viral RNA Metabolism
   Shringar Rao et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
2. DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs
   Marina K. Kukhanova et al, 2020, Molecules CrossRef
3. A Computational Approach with Biological Evaluation: Combinatorial Treatment of Curcumin and Exemestane Synergistically Regulates DDX3 Expression in Cancer Cell Lines
   Shailima Rampogu et al, 2020, Biomolecules CrossRef
4. The RNA helicase DDX3 induces neural crest by promoting AKT activity
   Mark Perfetto et al, 2020, Development CrossRef
5. PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells
   Fangfang Bi et al, 2021, Frontiers in Oncology CrossRef
6. Integrated Analysis of DEAD-Box Helicase 56: A Potential Oncogene in Osteosarcoma
   Chen Zhu et al, 2020, Frontiers in Bioengineering and Biotechnology CrossRef
7. Aberrant Splicing Events and Epigenetics in Viral Oncogenomics: Current Therapeutic Strategies
   Flavia Zita Francies et al, 2021, Cells CrossRef
8. Interactions of the C-Terminal Truncated DEAD-Box Protein DDX3X With RNA and Nucleotide Substrates
   Anthony F. T. Moore et al, 2021, ACS Omega CrossRef
9. The FHP01 DDX3X Helicase Inhibitor Exerts Potent Anti-Tumor Activity In Vivo in Breast Cancer Pre-Clinical Models
   Lisa Gherardini et al, 2021, Cancers CrossRef
10. Research progress in molecular pathology markers in medulloblastoma
    Zixuan Zhou et al, 2023, Exploration of Targeted Anti-tumor Therapy CrossRef
11. Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variation
    Elizabeth J. Radford et al, 2023, Nature Communications CrossRef
12. Cytoplasmic DDX3 as prognosticator in male breast cancer
    Carmen C. van der Pol et al, 2021, Virchows Archiv CrossRef
13. DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective
    Massimiliano Secchi et al, 2022, Cancers CrossRef
14. Proteomic Analysis of Quercetin-Treated K562 Cells
    Fabrizia Brisdelli et al, 2019, International Journal of Molecular Sciences CrossRef
15. Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
    Irene Vanni et al, 2020, Frontiers in Molecular Biosciences CrossRef
16. Novel Butein Derivatives Repress DDX3 Expression by Inhibiting PI3K/AKT Signaling Pathway in MCF-7 and MDA-MB-231 Cell Lines
    Shailima Rampogu et al, 2021, Frontiers in Oncology CrossRef
17. Level of Murine DDX3 RNA Helicase Determines Phenotype Changes of Hepatocytes In Vitro and In Vivo
    Olga Sergeeva et al, 2021, International Journal of Molecular Sciences CrossRef
18. Broad genomic workup including optical genome mapping uncovers a DDX3X: MLLT10 gene fusion in acute myeloid leukemia
    Verena Nilius-Eliliwi et al, 2022, Frontiers in Oncology CrossRef
19. The human DEAD-box helicase DDX3X as a regulator of mRNA translation
    Cathal S. Ryan et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
20. Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor:—an in silico and in vitro approach
    Ravinder Doneti et al, 2022, Medical Oncology CrossRef